Invention Grant
- Patent Title: Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors
-
Application No.: US15635920Application Date: 2017-06-28
-
Publication No.: US10646567B2Publication Date: 2020-05-12
- Inventor: Heather Maecker , Bryan Irving
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61K31/4184 ; A61K31/4355 ; A61K31/44 ; A61K31/4523 ; A61K31/519 ; A61K39/395 ; A61K47/62 ; C07K16/28 ; A61K47/64 ; A61K39/00
Abstract:
The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer.
Public/Granted literature
- US20180021431A1 METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS Public/Granted day:2018-01-25
Information query
